Acorda Therapeutics Investors

Acorda Therapeutics is a biopharmaceutical company based in Hawthorne, New York, established in 1995 The organization is dedicated to developing innovative therapies for neurological disorders Acorda Therapeutics has made significant investments in research and development, totaling approximately $33,000,000 The company collaborates with government offices and university programs to advance its scientific initiatives Its mission is to improve the lives of individuals affected by neurological conditions through groundbreaking treatments

Founded Date: 1995
Headquarters: USA
Technology: Immunotherapy
Employee Number: 251-500
Industry: FemTech
Estimated Revenue: $50M to $100M
Number Of Exists: N/A
Funding Status: IPO
Investor Type: Government Offices & University Programs
Investment Stage: N/A